Advancing Compounding Standards: Insights From the USP Compounding Implementation Workshop
Pharmacy Times
NOVEMBER 21, 2024
The workshop addressed trends, initiatives, and regulations for quality compounding.
Pharmacy Times
NOVEMBER 21, 2024
The workshop addressed trends, initiatives, and regulations for quality compounding.
PharmaTech
JULY 31, 2023
The Leistritz Plastics Compounding Twin Extrusion Workshop is a workshop designed to instruct industry professionals on continuous manufacturing via twin screw extrusion.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
NOVEMBER 1, 2024
At the Indian Pharmaceutical Alliance’s (IPA) virtual 9th Advanced Good Manufacturing Practices (GMP) Workshop Dr Rajeev Raghuvanshi, Drugs Controller General of India, CDSCO, Government of India commented, “At the heart of the pharmaceutical industry lies one unwavering principle: Quality. .”
pharmaphorum
AUGUST 24, 2020
SMi Reports: SMi Group have made the decision due to travel restrictions to open the conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on October 28 and 29 2020. Workshop B- Mycoplasma testing by anyone, anywhere and anytime! Workshops: October 30th, 2020.
pharmaphorum
MARCH 14, 2022
Novel Compounds and Treatments for Pain: Opioids and the Alternatives. Interactive Workshop on Friday 6 May 2022 on… Molecular and Cellular Pathophysiology of Pain Resolution. Workshop Leaders: Luda Diatchenko, Canada Research Chair in Human Pain Genetics, Department of Anesthesia, Faculty of Medicine, McGill University.
pharmaphorum
NOVEMBER 24, 2022
Dr Catherine Kettleborough, lead of the LifeArc Chronic Respiratory Infection Translational Challenge, said: “Repurposing an existing drug or compound is a faster way of getting new treatments to patients. Travel to hospital for regular check-ups is frequently needed. In 2019, the charity received a windfall of nearly $1.3
Quality Matters
NOVEMBER 11, 2022
FDA) workshop , my fellow panelist and I addressed the latest developments in the identification and control of nitrosamines in pharmaceutical products. Nitrosamines have represented a significant challenge for industry and regulators for some time. Earlier this year, at a U.S. Food and Drug Administration (U.S.
Let's personalize your content